Leap Therapeutics, Inc.

NASDAQ:LPTX

2.88 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 000.63400000000.3750.3750.3750.3750.3750.3750.3750.3750000000000000000000000000000
Cost of Revenue 00.0050.110.1070.1060.1040.1010.10.1060.1080.37500000000000000000000000000000000000
Gross Profit 0-0.0050.524-0.107-0.106-0.104-0.101-0.1-0.106-0.10800.3750.3750.3750.3750.3750.3750.3750000000000000000000000000000
Gross Profit Ratio 000.82600000000.00111111110000000000000000000000000000
Reseach & Development Expenses 17.88511.29911.68511.50311.10438.94211.03412.10214.0457.7848.0710.0777.2066.8075.1015.3695.354.6035.6685.7726.1366.797.346.1583.9913.5854.4166.8024.8816.4047.4225.6596.1244.0871.1124.1864.825.2515.6793.9463.222.6973.022.4461.7591.95
General & Administrative Expenses 3.3673.5263.1353.333.5583.7842.9093.1862.8552.8482.7932.4382.7952.742.4282.5142.5212.1532.6042.1512.3252.0052.0632.1422.6032.1132.131.782.1353.8040.7341.3691.071.0560.6041.5721.9321.6121.1991.6891.1680.6550.8352.9330.5610.366
Selling & Marketing Expenses 00-0.110000000000000000000000000000000000000000000
SG&A 3.3673.5263.0253.333.5583.7842.9093.1862.8552.8482.7932.4382.7952.742.4282.5142.5212.1532.6042.1512.3252.0052.0632.1422.6032.1132.131.782.1353.8040.7341.3691.071.0560.6041.5721.9321.6121.1991.6891.1680.6550.8352.9330.5610.366
Other Expenses 000.27200-0.272-0.775-0.652-0.587-0.0371.584-1.269-0.244-0.07100000000.0750000-0.0550000000000000000000
Operating Expenses 21.25214.82514.7114.83314.36442.45413.16814.63616.31310.59511.22111.2469.7579.4767.6417.6557.8416.6718.2697.938.48.729.4038.36.5945.6986.5468.5827.01610.2088.1567.0287.1945.1431.7165.7586.7526.8636.8785.6354.3883.3523.8555.3792.322.316
Operating Income -21.252-14.825-14.82-14.833-14.662-42.726-13.943-15.288-16.9-10.632-10.488-12.14-9.626-9.172-7.154-7.508-7.496-6.381-8.272-7.923-8.461-8.795-8.971-8.599-6.837-6.344-6.546-8.582-7.016-10.208-8.156-7.028-7.194-5.143-1.716-5.758-6.752-6.863-7.541-5.635-4.388-3.352-3.855-5.379-2.32-2.316
Operating Income Ratio 00-23.3750000000-27.968-32.373-25.669-24.459-19.077-20.021-19.989-17.0160000000000000000000000000000
Total Other Income Expenses Net 1.1241.0052.3551.137-0.1830.8631.9880.194-0.1240.2560.031-0.26-0.129-0.0210.5490.2370.943-0.9910.24-0.08-0.0760.04210.7841.544-0.884-4.995-0.2561.7480.0620.8652.9360.133-0.0580.1090.019-0.0060.1170.008-0.094-4.4210.016-0.0130.05-4.7780.001-0.003
Income Before Tax -20.128-13.82-12.465-13.696-13.39-41.863-11.955-15.094-17.024-10.376-10.812-11.139-9.526-9.134-6.712-7.057-6.516-7.231-7.999-7.935-8.366-8.6031.5-6.632-7.364-10.622-6.75-6.815-6.905-9.414-5.731-7.277-7.477-5.147-1.697-5.764-6.635-6.855-7.635-10.056-4.372-3.357-3.805-10.157-2.319-1.894
Income Before Tax Ratio 00-19.6610000000-28.832-29.704-25.403-24.357-17.899-18.819-17.376-19.2830000000000000000000000000000
Income Tax Expense -0.202-0.0050.6640.199-0.016-0.8630.1470.8070.733-0.235-0.0240.0090.104-0.088-0.0020.0170.0130.012-0.0030.0050.1730.0070.020.0040.0080.006-0.1570-0.0490.1213.4470.3820.22800.1560.0650.0390.048-0.04700.0380.040.050.0490.05-0.425
Net Income -20.128-13.82-12.465-13.696-13.39-41-12.102-15.901-17.757-10.141-10.788-11.139-9.526-9.134-6.71-7.057-6.516-7.231-7.996-7.935-8.366-8.6031.48-6.632-7.364-10.622-6.593-6.815-6.905-9.414-5.731-7.277-7.477-5.147-1.697-5.829-6.674-6.903-7.588-10.056-4.41-3.397-3.855-10.206-2.369-1.894
Net Income Ratio 00-19.6610000000-28.768-29.704-25.403-24.357-17.893-18.819-17.376-19.2830000000000000000000000000000
EPS -0.51-0.51-0.46-0.51-0.91-3.17-1.07-1.4-1.57-0.9-0.95-1.42-1.25-1.2-0.88-0.92-1.24-2.29-3.3-3.32-3.65-4.471.01-4.51-5.01-8.53-6.06-7.25-7.35-13.55-6.1-4.26-4.38-3.01-0.99-3.19-3.6-3.8-4.67-7.03-2.73-4.56-5.18-13.71-3.18-2.54
EPS Diluted -0.51-0.51-0.46-0.51-0.91-3.17-1.07-1.4-1.57-0.9-0.95-1.42-1.25-1.2-0.88-0.92-1.24-2.29-3.3-3.32-3.65-4.471.01-4.36-5.01-8.53-6.05-7.25-7.35-13.55-6.1-4.26-4.38-3.01-0.99-3.19-3.6-3.8-4.67-7.03-2.73-4.56-5.18-13.71-3.18-2.54
EBITDA -21.252-14.825-14.71-14.833-13.101-41.606-12.647-14.272-16.27-10.586-10.841-10.863-9.381-9.099-7.815-7.178-7.314-6.027-8.237-7.838-8.281-8.449-9.283-8.159-6.46-5.609-6.494-8.553-6.967-10.133-5.212-7.012-7.19-5.143-1.436-5.732-6.42-6.701-7.513-5.472-4.221-3.186-3.692-5.22-2.161-2.157
EBITDA Ratio 00-23.2020000000-28.909-28.968-25.016-24.264-20.84-19.141-19.504-16.0720000000000000000000000000000